Parkinsons Disease Industry Analysis, Trend, Identifying and Commercializing First-in-Class Innovation Research Report | Frontier Pharma

Parkinson’s Disease (PD) is the second most common neurodegenerative disease after Alzheimer’s disease, affecting around 7.4 million people worldwide. It is caused by the progressive loss of dopamine-producing neurons in the substantia nigra within the basal ganglia. The main motor symptoms are tremors, bradykinesia and rigidity, although symptoms vary between individuals. As the disease progresses to more advanced stages, increasing symptoms and complications develop, which can cause severe disability in patients. Browse Full Report With TOC @ http://www.researchmoz.us/frontier-pharma-parkinsons-disease-identifying-and-commercializing-first-in-class-innovation-report.html
http://www.researchmoz.us/frontier-pharma-parkinsons-disease-identifying-and-commercializing-first-in-class-innovation-report.html